Treatment of cystoid macular edema secondary to retinitis pigmentosa: A systematic review
There are various treatments for cystoid macular edema (CME) secondary to retinitis pigmentosa (RP); however, the evidence for these treatments has not been previously systematically reviewed. Our review that includes 23 studies shows that oral carbonic anhydrase inhibitors (CAI) (including acetazolamide, methazolamide) and topical CAI (dorzolamide and brinzolamide) are effective first line treatments. In patients unresponsive to CAI treatment, intravitreal steroids (triamcinolone acetonide and sustained-release dexamethasone implant), oral corticosteroid (Deflazacort), intravitreal anti-vascular endothelial growth factor agents (ranibizumab and bevacizumab), grid laser photocoagulation, pars plana vitrectomy, or ketorolac were also effective in improving CME secondary to RP.
Source: Survey of Ophthalmology - Category: Opthalmology Authors: Malini Bakthavatchalam, Frank H.P. Lai, Shi Song Rong, Danny S. Ng, Marten E. Brelen Tags: Reviews Source Type: research
More News: Acetazolamide | Avastin | Corticosteroid Therapy | Dexamethasone | Lucentis | Opthalmology | Ranibizumab Injection | Retinitis Pigmentosa | Study | Triamcinolone